Pfizer Inc.



+56.6% last 12 months

Market Cap

$312 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$32.45 - $61.71

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.54 (2.77%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $312 Billion
Enterprise Value $322 Billion
Dividend Yield $1.54 (2.77%)
1 Year Return +59.3%
52-Week High $61.71
52-Week Low $32.45
Beta -0.0
Outstanding Shares 5.61 Billion
Avg 30 Day Volume 45.5 Million


P/E Ratio 16.25
PEG 5.99
Earnings per Share $3.38
Price to Sales Ratio 5.0
Price to Book Ratio 4.23
Revenue to Enterprise Value 5.06
EBIT to Enterprise Value 19.38
Total Debt to Enterprise Value 0.12
Debt to Equity 0.53


Revenue $63.6 Billion
Gross Profit $40.9 Billion
EBIT $16.6 Billion
Net Income $19.2 Billion
Profit Margin 30.16%
Quarterly Earnings Growth (YoY) +271.3%
Return on Equity 25.34%
Return on Assets 10.7%
Return on Invested Capital 12.09%

Insider trades

No purchases

2,500 shares sold (1 transactions)

No purchases

No sells

No purchases

47,316 shares sold (3 transactions)

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Pfizer Inc.

CEO: Albert Bourla

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Merck & Co Inc
Merck & Co Inc
Johnson & Johnson
Johnson & Johnson
Lilly(Eli) & Co
Lilly(Eli) & Co
Novartis AG - ADR
Novartis AG - ADR
Glaxosmithkline plc - ADR
Glaxosmithkline plc - ADR
Abbott Laboratories
Abbott Laboratories
Astrazeneca plc - ADR
Astrazeneca plc - ADR